Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

Published:2023-11 Issue:11 Volume:7 Page:e968
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Janssen Luca L.G.¹²,Westers Theresia M.¹²,Rovers Jeroen³,Valk Peter J.M.⁴,Cloos Jacqueline¹²,de Gruijl Tanja D.²⁵,van de Loosdrecht Arjan A.¹²

Affiliation:

1. Amsterdam UMC, Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands

2. Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands

3. Mendus AB, R&D Center, Leiden, The Netherlands

4. Erasmus University Medical Center, Department of Hematology, Rotterdam, The Netherlands

5. Amsterdam UMC, Vrije Universiteit, Department of Medical Oncology, Amsterdam, The Netherlands

Publisher

Wiley

Subject

Hematology

Reference14 articles.

1. Treatment of MDS.;Platzbecker;Blood,2019

2. Towards precision medicine for AML.;Döhner;Nat Rev Clin Oncol,2021

3. Maintenance therapy for AML: are we there yet?;Wei;Blood,2019

4. A review of cancer immunotherapy: from the past, to the present, to the future.;Esfahani;Curr Oncol,2020

5. Dendritic cell-based Immunotherapy of acute myeloid leukemia.;Van Acker;J Clin Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP